Home › About
Our Company
PrintBio is a privately held, commercial-stage medical device company and creator of the first programmable surgical mesh platform. Using proprietary polymer science and precision 3D printing, PrintBio engineers resorbable synthetic meshes — DynaFlex™ and DynaForm™ Programmable Surgical Mesh — with region- and vector-specific mechanical performance designed to improve tissue response and reduce post-operative complications.
WHO WE ARE
Mesh, designed — not just manufactured
PrintBio works with leading surgeons to bring precision 3D printing to soft-tissue repair. Where conventional mesh delivers one fixed strength and stretch everywhere, our platform sets strength and flexibility by region and by direction, produces mesh in contoured three-dimensional forms, and resorbs as the patient’s own tissue takes over.
AT A GLANCE
Headquarters & manufacturing
Long Island City, New York
Products
DynaFlex™ and DynaForm™ Programmable Surgical Mesh
Focus
Hernia repair, soft-tissue reinforcement, plastic & reconstructive surgery
Designed and manufactured in Long Island City, New York
Validated processes
3D-print process validated; EO sterilization validated to ISO 11135; packaging validated to ISO 11607.
Vertically integrated
Polymer processing, 3D printing, sterilization and packaging — all on site, under one roof.
Built on quality
Quality system built to FDA 21 CFR Part 820. R&D, QA/QC and manufacturing together.
PrintBio, Inc.